INVESTOR RELATIONS

SEC Filings

SEC Filings

Other Filings
Filing Description Filing Type Period Covered Filing Date  
8-K 8-K 6/11/2020 6/12/2020
Abstract: 8-K filed by Global Medical REIT Inc. (GMRE) covering Shareholder Director Nomination.
Registration Statement S-3 6/9/2020
Abstract: Registrant filed a registration statement for up to $ 750 million of certain types of securities. Proceeds from the offering will be used for general corporate purposes.
8-K 8-K 6/2/2020 6/2/2020
Abstract: 8-K filed by Global Medical REIT Inc. (GMRE) covering Regulation FD Disclosure and Financial Statements and Exhibits.
10-Q 10-Q 3/31/2020 5/8/2020
8-K 8-K 5/6/2020 5/6/2020
Abstract: 8-K filed by Global Medical REIT Inc. (GMRE) covering Results of Operations and Financial Condition and Financial Statements and Exhibits.
10-K 10-K/A 12/31/2019 4/27/2020
Abstract: Registrant filed its amendment No. 1 to provide corrected information required in Part III of its Form 10-K.
Registration Statement D 4/17/2020
Registration Statement D 4/17/2020
Registration Statement D 4/17/2020
Registration Statement D 4/17/2020
Registration Statement D 4/17/2020
8-K 8-K 4/9/2020 4/10/2020
Abstract: 8-K filed by Global Medical REIT Inc. (GMRE) covering Unregistered Sales of Equity Securities.
8-K 8-K 3/17/2020 3/18/2020
Abstract: 8-K filed by Global Medical REIT Inc. (GMRE) covering Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers and Financial Statements and Exhibits.
10-K 10-K 12/31/2019 3/9/2020
13-D SC 13G/A 3/6/2020
8-K 8-K 3/3/2020 3/5/2020
Abstract: 8-K filed by Global Medical REIT Inc. (GMRE) covering Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers and Financial Statements and Exhibits.
8-K 8-K 3/3/2020 3/4/2020
Abstract: On March 4, registrant reported its net income for the quarter and its net income for the year ended Dec. 31, 2019. On March 3, registrant declared a dividend of 20 cents per share, payable April 9 to shareholders as of March 25. The earnings supplemental was included by exhibit.
13-D SC 13G 2/11/2020
13-D SC 13G 2/7/2020
13-D SC 13G/A 2/6/2020

Displaying 1 to 20 (of 195 filings)